S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: USExchange: Nasdaq
DilutionScan read 27 of AYTU BIOPHARMA, INC's SEC filings and found 8 warrant series, 1 ATM program, 1 shelf registration, 3 S-1 registrations and 1 completed offering on file for AYTU. The latest dilution event on file is a warrant issuance on Mar 31, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: effective shelf · latest dilution event 217 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Mar 31, 2026 · Warrant Issuance
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Proposed maximum
Shares registered
Proposed maximum
Shares registered
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2021
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Drug Manufacturers - Specialty & Generic. All tickers A to Z